Rare surfactant‐related variants in familial and sporadic pulmonary fibrosis
The role of constitutional genetic defects in idiopathic pulmonary fibrosis (IPF) is increasingly appreciated. Monogenic disorders associated with IPF affect two pathways: telomere maintenance, accounting for approximately 10% of all patients with IPF, and surfactant biology, responsible for 1%–3% o...
Gespeichert in:
Veröffentlicht in: | Human mutation 2022-12, Vol.43 (12), p.2091-2101 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2101 |
---|---|
container_issue | 12 |
container_start_page | 2091 |
container_title | Human mutation |
container_volume | 43 |
creator | Sutton, Rachel M. Bittar, Humberto Trejo Sullivan, Daniel I. Silva, Agustin Gil Bahudhanapati, Harinath Parikh, Anishka H. Zhang, Yingze Gibson, Kevin McDyer, John F. Kass, Daniel J. Alder, Jonathan K. |
description | The role of constitutional genetic defects in idiopathic pulmonary fibrosis (IPF) is increasingly appreciated. Monogenic disorders associated with IPF affect two pathways: telomere maintenance, accounting for approximately 10% of all patients with IPF, and surfactant biology, responsible for 1%–3% of cases and often co‐occurring with lung cancer. We examined the prevalence of rare variants in five surfactant‐related genes, SFTPA1, SFPTA2, SFTPC, ABCA3, and NKX2‐1, that were previously linked to lung disease in whole genome sequencing data from 431 patients with IPF. We identified functionally deleterious rare variants in SFTPA2 with a prevalence of 1.3% in individuals with and without a family history of IPF. All individuals had no personal history of lung cancer, but substantial bronchiolar metaplasia was noted on lung explants and biopsies. Five patients had novel missense variants in NKX2‐1, but the contribution to disease is unclear. In general, patients were younger and had longer telomeres compared with the majority of patients with IPF suggesting that these features may be useful for identifying this subset of patients in the clinic. These data suggest that SFTPA2 variants may be more common in unselected IPF cohorts and may manifest in the absence of personal/family history of lung cancer or IPF. |
doi_str_mv | 10.1002/humu.24476 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9771972</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2753557464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4486-c45b044439461263af9bcd0482805f373fc678dd22343587b6c498cd06c1b6273</originalsourceid><addsrcrecordid>eNp9kd1KHDEYhoMoXWt74gXIgCelsDY_X5LJiSBiq7C2ULrHIZPJuJHMzJrMWDzzEnqNXonZ7irqgSdJ-PLw8CYvQvsEHxGM6bfF2I5HFECKLbRLsCqneQzbqzNXUykVTNDHlK4xxiXn7AOaMEEYl1jtop-_TXRFGmNj7GC64eH-X3TBDK4ubk30eZIK3xWNaX3wJhSmq4u07KOpvS2WY2j7zsS7ovFV7JNPn9BOY0Jynzf7Hpp_P_tzej6d_fpxcXoym1qAUuSVVxgAmAJBqGCmUZWtMZS0xLxhkjVWyLKuKWXAeCkrYUGVmRCWVIJKtoeO197lWLWutq4bogl6GX2b4-jeeP36pvMLfdXfaiUlUZJmwZeNIPY3o0uDbn2yLgTTuX5MmkoiFDABPKOHb9Drfoxdfl6mOONcgoBMfV1TNn9Eiq55DkOwXtWkVzXp_zVl-OBl_Gf0qZcMkDXw1wd3945Kn88v52vpI0zRnsI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2753557464</pqid></control><display><type>article</type><title>Rare surfactant‐related variants in familial and sporadic pulmonary fibrosis</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Sutton, Rachel M. ; Bittar, Humberto Trejo ; Sullivan, Daniel I. ; Silva, Agustin Gil ; Bahudhanapati, Harinath ; Parikh, Anishka H. ; Zhang, Yingze ; Gibson, Kevin ; McDyer, John F. ; Kass, Daniel J. ; Alder, Jonathan K.</creator><creatorcontrib>Sutton, Rachel M. ; Bittar, Humberto Trejo ; Sullivan, Daniel I. ; Silva, Agustin Gil ; Bahudhanapati, Harinath ; Parikh, Anishka H. ; Zhang, Yingze ; Gibson, Kevin ; McDyer, John F. ; Kass, Daniel J. ; Alder, Jonathan K.</creatorcontrib><description>The role of constitutional genetic defects in idiopathic pulmonary fibrosis (IPF) is increasingly appreciated. Monogenic disorders associated with IPF affect two pathways: telomere maintenance, accounting for approximately 10% of all patients with IPF, and surfactant biology, responsible for 1%–3% of cases and often co‐occurring with lung cancer. We examined the prevalence of rare variants in five surfactant‐related genes, SFTPA1, SFPTA2, SFTPC, ABCA3, and NKX2‐1, that were previously linked to lung disease in whole genome sequencing data from 431 patients with IPF. We identified functionally deleterious rare variants in SFTPA2 with a prevalence of 1.3% in individuals with and without a family history of IPF. All individuals had no personal history of lung cancer, but substantial bronchiolar metaplasia was noted on lung explants and biopsies. Five patients had novel missense variants in NKX2‐1, but the contribution to disease is unclear. In general, patients were younger and had longer telomeres compared with the majority of patients with IPF suggesting that these features may be useful for identifying this subset of patients in the clinic. These data suggest that SFTPA2 variants may be more common in unselected IPF cohorts and may manifest in the absence of personal/family history of lung cancer or IPF.</description><identifier>ISSN: 1059-7794</identifier><identifier>EISSN: 1098-1004</identifier><identifier>DOI: 10.1002/humu.24476</identifier><identifier>PMID: 36135709</identifier><language>eng</language><publisher>United States: Hindawi Limited</publisher><subject>ABCA3 ; Biopsy ; Explants ; Family medical history ; Fibrosis ; genetics ; Genomes ; Humans ; Idiopathic Pulmonary Fibrosis - genetics ; IPF ; Lung cancer ; Lung diseases ; Lung Neoplasms - genetics ; Metaplasia ; Mutation, Missense ; NKX2‐1 ; Pulmonary fibrosis ; Pulmonary Surfactants ; SFTPA1 ; SFTPA2 ; SFTPC ; Surface-Active Agents ; Surfactants ; Telomeres ; Whole genome sequencing</subject><ispartof>Human mutation, 2022-12, Vol.43 (12), p.2091-2101</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC.</rights><rights>2022 The Authors. Human Mutation published by Wiley Periodicals LLC.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4486-c45b044439461263af9bcd0482805f373fc678dd22343587b6c498cd06c1b6273</citedby><cites>FETCH-LOGICAL-c4486-c45b044439461263af9bcd0482805f373fc678dd22343587b6c498cd06c1b6273</cites><orcidid>0000-0003-3741-6512</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhumu.24476$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhumu.24476$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36135709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sutton, Rachel M.</creatorcontrib><creatorcontrib>Bittar, Humberto Trejo</creatorcontrib><creatorcontrib>Sullivan, Daniel I.</creatorcontrib><creatorcontrib>Silva, Agustin Gil</creatorcontrib><creatorcontrib>Bahudhanapati, Harinath</creatorcontrib><creatorcontrib>Parikh, Anishka H.</creatorcontrib><creatorcontrib>Zhang, Yingze</creatorcontrib><creatorcontrib>Gibson, Kevin</creatorcontrib><creatorcontrib>McDyer, John F.</creatorcontrib><creatorcontrib>Kass, Daniel J.</creatorcontrib><creatorcontrib>Alder, Jonathan K.</creatorcontrib><title>Rare surfactant‐related variants in familial and sporadic pulmonary fibrosis</title><title>Human mutation</title><addtitle>Hum Mutat</addtitle><description>The role of constitutional genetic defects in idiopathic pulmonary fibrosis (IPF) is increasingly appreciated. Monogenic disorders associated with IPF affect two pathways: telomere maintenance, accounting for approximately 10% of all patients with IPF, and surfactant biology, responsible for 1%–3% of cases and often co‐occurring with lung cancer. We examined the prevalence of rare variants in five surfactant‐related genes, SFTPA1, SFPTA2, SFTPC, ABCA3, and NKX2‐1, that were previously linked to lung disease in whole genome sequencing data from 431 patients with IPF. We identified functionally deleterious rare variants in SFTPA2 with a prevalence of 1.3% in individuals with and without a family history of IPF. All individuals had no personal history of lung cancer, but substantial bronchiolar metaplasia was noted on lung explants and biopsies. Five patients had novel missense variants in NKX2‐1, but the contribution to disease is unclear. In general, patients were younger and had longer telomeres compared with the majority of patients with IPF suggesting that these features may be useful for identifying this subset of patients in the clinic. These data suggest that SFTPA2 variants may be more common in unselected IPF cohorts and may manifest in the absence of personal/family history of lung cancer or IPF.</description><subject>ABCA3</subject><subject>Biopsy</subject><subject>Explants</subject><subject>Family medical history</subject><subject>Fibrosis</subject><subject>genetics</subject><subject>Genomes</subject><subject>Humans</subject><subject>Idiopathic Pulmonary Fibrosis - genetics</subject><subject>IPF</subject><subject>Lung cancer</subject><subject>Lung diseases</subject><subject>Lung Neoplasms - genetics</subject><subject>Metaplasia</subject><subject>Mutation, Missense</subject><subject>NKX2‐1</subject><subject>Pulmonary fibrosis</subject><subject>Pulmonary Surfactants</subject><subject>SFTPA1</subject><subject>SFTPA2</subject><subject>SFTPC</subject><subject>Surface-Active Agents</subject><subject>Surfactants</subject><subject>Telomeres</subject><subject>Whole genome sequencing</subject><issn>1059-7794</issn><issn>1098-1004</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp9kd1KHDEYhoMoXWt74gXIgCelsDY_X5LJiSBiq7C2ULrHIZPJuJHMzJrMWDzzEnqNXonZ7irqgSdJ-PLw8CYvQvsEHxGM6bfF2I5HFECKLbRLsCqneQzbqzNXUykVTNDHlK4xxiXn7AOaMEEYl1jtop-_TXRFGmNj7GC64eH-X3TBDK4ubk30eZIK3xWNaX3wJhSmq4u07KOpvS2WY2j7zsS7ovFV7JNPn9BOY0Jynzf7Hpp_P_tzej6d_fpxcXoym1qAUuSVVxgAmAJBqGCmUZWtMZS0xLxhkjVWyLKuKWXAeCkrYUGVmRCWVIJKtoeO197lWLWutq4bogl6GX2b4-jeeP36pvMLfdXfaiUlUZJmwZeNIPY3o0uDbn2yLgTTuX5MmkoiFDABPKOHb9Drfoxdfl6mOONcgoBMfV1TNn9Eiq55DkOwXtWkVzXp_zVl-OBl_Gf0qZcMkDXw1wd3945Kn88v52vpI0zRnsI</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Sutton, Rachel M.</creator><creator>Bittar, Humberto Trejo</creator><creator>Sullivan, Daniel I.</creator><creator>Silva, Agustin Gil</creator><creator>Bahudhanapati, Harinath</creator><creator>Parikh, Anishka H.</creator><creator>Zhang, Yingze</creator><creator>Gibson, Kevin</creator><creator>McDyer, John F.</creator><creator>Kass, Daniel J.</creator><creator>Alder, Jonathan K.</creator><general>Hindawi Limited</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3741-6512</orcidid></search><sort><creationdate>202212</creationdate><title>Rare surfactant‐related variants in familial and sporadic pulmonary fibrosis</title><author>Sutton, Rachel M. ; Bittar, Humberto Trejo ; Sullivan, Daniel I. ; Silva, Agustin Gil ; Bahudhanapati, Harinath ; Parikh, Anishka H. ; Zhang, Yingze ; Gibson, Kevin ; McDyer, John F. ; Kass, Daniel J. ; Alder, Jonathan K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4486-c45b044439461263af9bcd0482805f373fc678dd22343587b6c498cd06c1b6273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>ABCA3</topic><topic>Biopsy</topic><topic>Explants</topic><topic>Family medical history</topic><topic>Fibrosis</topic><topic>genetics</topic><topic>Genomes</topic><topic>Humans</topic><topic>Idiopathic Pulmonary Fibrosis - genetics</topic><topic>IPF</topic><topic>Lung cancer</topic><topic>Lung diseases</topic><topic>Lung Neoplasms - genetics</topic><topic>Metaplasia</topic><topic>Mutation, Missense</topic><topic>NKX2‐1</topic><topic>Pulmonary fibrosis</topic><topic>Pulmonary Surfactants</topic><topic>SFTPA1</topic><topic>SFTPA2</topic><topic>SFTPC</topic><topic>Surface-Active Agents</topic><topic>Surfactants</topic><topic>Telomeres</topic><topic>Whole genome sequencing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sutton, Rachel M.</creatorcontrib><creatorcontrib>Bittar, Humberto Trejo</creatorcontrib><creatorcontrib>Sullivan, Daniel I.</creatorcontrib><creatorcontrib>Silva, Agustin Gil</creatorcontrib><creatorcontrib>Bahudhanapati, Harinath</creatorcontrib><creatorcontrib>Parikh, Anishka H.</creatorcontrib><creatorcontrib>Zhang, Yingze</creatorcontrib><creatorcontrib>Gibson, Kevin</creatorcontrib><creatorcontrib>McDyer, John F.</creatorcontrib><creatorcontrib>Kass, Daniel J.</creatorcontrib><creatorcontrib>Alder, Jonathan K.</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Human mutation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sutton, Rachel M.</au><au>Bittar, Humberto Trejo</au><au>Sullivan, Daniel I.</au><au>Silva, Agustin Gil</au><au>Bahudhanapati, Harinath</au><au>Parikh, Anishka H.</au><au>Zhang, Yingze</au><au>Gibson, Kevin</au><au>McDyer, John F.</au><au>Kass, Daniel J.</au><au>Alder, Jonathan K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rare surfactant‐related variants in familial and sporadic pulmonary fibrosis</atitle><jtitle>Human mutation</jtitle><addtitle>Hum Mutat</addtitle><date>2022-12</date><risdate>2022</risdate><volume>43</volume><issue>12</issue><spage>2091</spage><epage>2101</epage><pages>2091-2101</pages><issn>1059-7794</issn><eissn>1098-1004</eissn><abstract>The role of constitutional genetic defects in idiopathic pulmonary fibrosis (IPF) is increasingly appreciated. Monogenic disorders associated with IPF affect two pathways: telomere maintenance, accounting for approximately 10% of all patients with IPF, and surfactant biology, responsible for 1%–3% of cases and often co‐occurring with lung cancer. We examined the prevalence of rare variants in five surfactant‐related genes, SFTPA1, SFPTA2, SFTPC, ABCA3, and NKX2‐1, that were previously linked to lung disease in whole genome sequencing data from 431 patients with IPF. We identified functionally deleterious rare variants in SFTPA2 with a prevalence of 1.3% in individuals with and without a family history of IPF. All individuals had no personal history of lung cancer, but substantial bronchiolar metaplasia was noted on lung explants and biopsies. Five patients had novel missense variants in NKX2‐1, but the contribution to disease is unclear. In general, patients were younger and had longer telomeres compared with the majority of patients with IPF suggesting that these features may be useful for identifying this subset of patients in the clinic. These data suggest that SFTPA2 variants may be more common in unselected IPF cohorts and may manifest in the absence of personal/family history of lung cancer or IPF.</abstract><cop>United States</cop><pub>Hindawi Limited</pub><pmid>36135709</pmid><doi>10.1002/humu.24476</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-3741-6512</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1059-7794 |
ispartof | Human mutation, 2022-12, Vol.43 (12), p.2091-2101 |
issn | 1059-7794 1098-1004 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9771972 |
source | Wiley-Blackwell Journals; MEDLINE |
subjects | ABCA3 Biopsy Explants Family medical history Fibrosis genetics Genomes Humans Idiopathic Pulmonary Fibrosis - genetics IPF Lung cancer Lung diseases Lung Neoplasms - genetics Metaplasia Mutation, Missense NKX2‐1 Pulmonary fibrosis Pulmonary Surfactants SFTPA1 SFTPA2 SFTPC Surface-Active Agents Surfactants Telomeres Whole genome sequencing |
title | Rare surfactant‐related variants in familial and sporadic pulmonary fibrosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T11%3A19%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rare%20surfactant%E2%80%90related%20variants%20in%20familial%20and%20sporadic%20pulmonary%20fibrosis&rft.jtitle=Human%20mutation&rft.au=Sutton,%20Rachel%20M.&rft.date=2022-12&rft.volume=43&rft.issue=12&rft.spage=2091&rft.epage=2101&rft.pages=2091-2101&rft.issn=1059-7794&rft.eissn=1098-1004&rft_id=info:doi/10.1002/humu.24476&rft_dat=%3Cproquest_pubme%3E2753557464%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2753557464&rft_id=info:pmid/36135709&rfr_iscdi=true |